Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Donepezil in Normalizing Brain Activation Patterns in People Genetically at Risk for Alzheimer's Disease

NCT00408525 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00408525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Donepezil in Normalizing Brain Activation Patterns in People Genetically at Risk for Alzheimer's Disease
Lead sponsor
Vanderbilt University
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2006
Completion date
August 24, 2012
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease